Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes?
Crossref DOI link: https://doi.org/10.1007/s13300-020-00878-y
Published Online: 2020-07-15
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hinton, William
Feher, Michael
Munro, Neil
de Lusignan, Simon http://orcid.org/0000-0002-8553-2641
Funding for this research was provided by:
AstraZeneca UK Limited
Text and Data Mining valid from 2020-07-15
Version of Record valid from 2020-07-15
Article History
Received: 28 April 2020
First Online: 15 July 2020